logo

Robert Pickard and Luke Vale Governments of all nations struggle to work out how best to use the limited resources available for health care. One key area of uncertainty is long te[...]
OR The Hare Becomes the Tortoise?? When I was a medical oncology trainee in 2001 looking for an area to specialise in my mentors told me prostate cancer was going to be the next bi[...]
The International Urology Journal Club on Twitter discussion for February 2103 was based upon the recently published Prostate Cancer Outcomes Study in the New England Journal of Me[...]
John W. Davis and Prokar Dasgupta* Departments of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA and *Guy’s Hospital, Kings College London, London, UK[...]
A case-mix-adjusted comparison of early oncological outcomes of open and robotic prostatectomy performed by experienced high volume surgeons Jonathan L. Silberstein*, Daniel Su*, L[...]
The idea of a joint fund-raising trek in support of Prostate Cancer UK (formerly Prostate Action) and Well-Being of Women (WoW) dates back to 2005, when almost 100 trekkers joined [...]
A recent editorial in the BMJ by Christopher Parker (Treating prostate cancer. BMJ 2012; 345: e5122) uses the “best available evidence” from the PIVOT study (Wilt TJ, et al) to arg[...]
Here’s my technique for anaesthetising patients for robotic-assisted laparoscopic radical prostatectomy and I’d be interested to hear any thoughts, comments and ideas. Pre-op. I tr[...]
Deep vein thromboses (DVT) and pulmonary embolism (PE) are rare, but potentially devastating, complications of major pelvic surgery. We have performed more than 1000 robot assisted[...]
Thanks for all the helpful input regarding my first blog post. Constructive criticism is always helpful, especially if I am to get better at this. If you haven’t read it, par[...]